Oruka Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2004 | 82.6% | 82.6% | — |
| FY2005 | 215.2% | 215.2% | — |
| FY2006 | 91.2% | 91.2% | — |
| FY2007 | 71.1% | 71.1% | — |
| FY2008 | 50.9% | 50.9% | — |
| FY2009 | -123.3% | -123.3% | — |
| FY2010 | -124.4% | -124.4% | -103.2% |
| FY2011 | -93.6% | -93.6% | -82.5% |
| FY2012 | -148.6% | -148.6% | -134.5% |
| FY2013 | -44.5% | -44.5% | -40.6% |
| FY2014 | -65.7% | -65.7% | -60.1% |
| FY2015 | -30.1% | -30.1% | -28.9% |
| FY2016 | -74.1% | -74.1% | -66.8% |
| FY2017 | -180.0% | -180.0% | -149.5% |
| FY2018 | -131.5% | -131.5% | -116.2% |
| FY2019 | -72.0% | -72.0% | -64.2% |
| FY2020 | -20.9% | -20.9% | -19.3% |
| FY2021 | -37.9% | -37.9% | -35.2% |
| FY2022 | -23.8% | -23.8% | -23.0% |
| FY2023 | -14.4% | -14.4% | -14.1% |
| FY2024 | -21.9% | -21.9% | -21.1% |
| FY2025 | -22.3% | -22.3% | -21.6% |